Zoetis/ZTS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Zoetis

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Ticker

ZTS

Sector

Healthcare

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Parsippany, United States

Employees

14,100
Website
www.zoetis.com

Zoetis Metrics

BasicAdvanced
$79B
Market cap
33.25
P/E ratio
$5.19
EPS
0.86
Beta
$1.56
Dividend rate
0.90%
Dividend yield
$79B
0.86
$1.56
3.331
1.712
134.125
134.6
29.95%
13.44%
13.99%
50.05%
33.25
9.09
15.6
78.6
45.34
0.90%
7.91%
17.49%
7.59%
11.85%
22.36%

What the Analysts think about Zoetis

Analyst Ratings

Majority rating from 18 analysts.
Buy

Zoetis Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
27.35% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.2B
-1.04%
Net income
$599M
14.10%
Profit margin
27.35%
15.30%

Zoetis Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.30%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.41
$1.36
$1.24
$1.38
-
Expected
$1.32
$1.36
$1.32
$1.34
$1.50
Surprise
7.19%
0.08%
-6.01%
3.30%
-

Zoetis News

AllArticlesVideos

Zoetis Named a Top Company for DE&I by Fair360 (Formerly DiversityInc.)

Business Wire·2 months ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS

PRNewsWire·2 months ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS

PRNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

Jul
18
Zoetis
Dividend·Ex-dividend
Sept
4
Zoetis
Dividend·Payment
$0.432
Per share

FAQs

What’s the current market cap for Zoetis stock?

Zoetis (ZTS) has a market cap of $79B as of July 03, 2024.

What is the P/E ratio for Zoetis stock?

The price to earnings (P/E) ratio for Zoetis (ZTS) stock is 33.25 as of July 03, 2024.

Does Zoetis stock pay dividends?

Yes, the Zoetis (ZTS) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $1.557 and the yield is 0.9%. Zoetis has a payout ratio of 29.95% on a trailing twelve-month basis.

When is the next Zoetis dividend payment date?

The next Zoetis (ZTS) dividend payment is scheduled for September 04, 2024.

What is the beta indicator for Zoetis?

Zoetis (ZTS) has a beta rating of 0.86. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Zoetis stock

Buy or sell Zoetis stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing